Skip to main content
Clinical Trials/CTRI/2025/03/081802
CTRI/2025/03/081802Not yet recruitingNot Applicable

COMPARATIVE EVALUATION OF CALCIUM HYDROXIDE AND SILVER DIAMINE FLUORIDE AS INDIRECT PULP CAPPING AGENTS IN PRIMARY MOLARS -A RANDOMIZED CONTROLLED TRIAL

Dr ATHIRA H1 site in 1 country33 target enrollmentStarted: March 25, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
33
Locations
1
Primary Endpoint
clinical and radiographic evaluation

Study Overview

Brief Summary

This randomized controlled trial compares calcium hydroxide and silver diamine fluoride (38% and 1:10%) as indirect pulp-capping agents in primary molars. A total of 33 teeth will be randomly assigned to three groups. Procedures include local anesthesia, rubber dam isolation , infected dentin removal, material application, and final restoration with a stainless steel crown.

Patients will be reviewed at 3 and 6 months, and clinical and radiographic evaluations will be performed to assess success. Double blinding will be implemented and the outcomes will be based on pain,inflammation,mobility , restoration retention, and radiographic changes

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
4.00 Year(s) to 9.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Primary molars with deep caries that are closer to a pulp with mild pain during mastication.
  • Primary molars showing positive transient response to thermal and electrical pulp testing 3) Primary molars with radiolucency, involving enamel and dentin with a Remaining Dentin Thickness (RDT) of 0.5-1.5 mm.

Exclusion Criteria

  • Deep caries with a history of spontaneous pain, and night pain.
  • Primary molars, with tenderness on palpation and percussion 3) Abscesses, sinus tract, or gingival inflammation 4) Pathological mobility 5) Radio graphical changes with radiolucencies involving pulp, widening of the periodontal ligament, irregular lamina dura, and periapical radiolucencies 6) Any systemic disease 7) Known allergy to silver.

Outcomes

Primary Outcomes

clinical and radiographic evaluation

Time Frame: ASSESSED AFTER 3 MONTHS AND 6 MONTHS

Secondary Outcomes

  • no outcomes(no time points)

Investigators

Sponsor
Dr ATHIRA H
Sponsor Class
Other [funded by myself]
Responsible Party
Principal Investigator
Principal Investigator

Dr ATHIRA H

PMS COLLEGE OF DENTAL SCIENCE AND RESEARCH

Study Sites (1)

Loading locations...

Similar Trials